Cash flow Henkel AG & Co. KGaA

Stocks

HEN3

DE0006048432

Specialty Chemicals

Market Closed - Xetra Other stock markets 19:35:27 10/07/2026 +04			5-day change	1st Jan Change
74.50 ^EUR	+0.51%		-1.11%	+7.07%

07-07	HENKEL VORZUEGE : DZ Bank gives a Buy rating	ZD
07-07	Henkel Wraps Up Purchase of Premium Hair Care Brand Olaplex	MT

79df0b3ea220a7035d08e61c785318ae.PyrFS9tYbeLaneJ4PVNag9R8-owAfKYkh6Mh2QV9lQ0.TVOmfOISCIWA0o89aAs7xJU4vr1oHshm3uVv73MerX1gWfwMsDZemrftow

Published financial data: HENKEL AG & CO. KGAA

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	20.07B	22.4B	21.51B	21.59B	20.5B
Total Revenues	20.07B	22.4B	21.51B	21.59B	20.5B
Cost of Goods Sold, Total	11B	12.92B	11.67B	10.66B	10.07B
Gross Profit	9.07B	9.47B	9.84B	10.92B	10.42B
Selling General & Admin Expenses, Total	6.03B	6.82B	6.79B	7.26B	6.99B
R&D Expenses	504M	544M	581M	632M	630M
Other Operating Expenses	-43M	-46M	-212M	13M	39M
Other Operating Expenses, Total	6.49B	7.32B	7.16B	7.9B	7.66B
Operating Income	2.57B	2.16B	2.68B	3.02B	2.76B
Interest Expense, Total	-46M	-73M	-106M	-113M	-99M
Interest And Investment Income	28M	37M	73M	101M	96M
Net Interest Expenses	-18M	-36M	-33M	-12M	-3M
Currency Exchange Gains (Loss)	-20M	-31M	-17M	-21M	-26M
Other Non Operating Income (Expenses)	-23M	-49M	-66M	-64M	-50M
EBT, Excl. Unusual Items	2.51B	2.04B	2.56B	2.92B	2.68B
Restructuring Charges	-228M	-404M	-267M	-201M	-
Impairment of Goodwill	-	-88M	-1M	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	46M	46M	-415M	-5M	46M
Asset Writedown	-208M	88M	2M	-	-
Insurance Settlements	17M	7M	5M	8M	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	8M	-	-	-	-
EBT, Incl. Unusual Items	2.15B	1.69B	1.89B	2.72B	2.73B
Income Tax Expense	519M	436M	549M	691M	670M
Earnings From Continuing Operations	1.63B	1.25B	1.34B	2.03B	2.06B
Net Income to Company	1.63B	1.25B	1.34B	2.03B	2.06B
Minority Interest	5M	5M	-22M	-25M	-23M
Net Income - (IS)	1.63B	1.26B	1.32B	2.01B	2.04B
Net Income to Common Incl Extra Items	1.63B	1.26B	1.32B	2.01B	2.04B
Net Income to Common Excl. Extra Items	1.63B	1.26B	1.32B	2.01B	2.04B
Per Share Items
Net EPS - Basic	3.76	2.94	3.14	4.79	4.91
Basic EPS - Continuing Operations	3.76	2.94	3.14	4.79	4.91
Basic Weighted Average Shares Outstanding	434M	428M	420M	419M	414M
Net EPS - Diluted	3.76	2.94	3.14	4.79	4.91
Diluted EPS - Continuing Operations	3.76	2.94	3.14	4.79	4.91
Diluted Weighted Average Shares Outstanding	434M	428M	420M	419M	414M
Normalized Basic EPS	3.63	2.99	3.77	4.29	3.99
Normalized Diluted EPS	3.63	2.99	3.77	4.29	3.99
Dividend Per Share	1.85	1.85	1.85	2.04	2.07
Payout Ratio	48.84	63.15	58.5	38.42	41.77
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	3.09B	2.69B	3.18B	3.52B	3.24B
EBITA	2.66B	2.24B	2.75B	3.09B	2.81B
EBIT	2.57B	2.16B	2.68B	3.02B	2.76B
EBITDAR	3.11B	2.71B	3.2B	3.54B	3.25B
Effective Tax Rate - (Ratio)	24.16	25.8	29.06	25.38	24.56
Total Current Taxes	759M	505M	520M	598M	536M
Total Deferred Taxes	-239M	-69M	29M	93M	134M
Normalized Net Income	1.58B	1.28B	1.58B	1.8B	1.65B
Interest on Long-Term Debt	14M	18M	21M	25M	25M
Non-Cash Pension Expense	0	-2M	4M	10M	43M
Supplemental Operating Expense Items
Selling and Marketing Expenses	5.1B	5.78B	5.72B	6.09B	5.79B
General and Administrative Expenses	928M	1.03B	1.07B	1.16B	1.19B
Research And Development Expense From Footnotes	727M	570M	587M	634M	630M
Net Rental Expense, Total	23M	20M	15M	14M	14M
Imputed Operating Lease Interest Expense	2.39M	3.32M	3.91M	3.52M	2.77M
Imputed Operating Lease Depreciation	20.61M	16.68M	11.09M	10.48M	11.23M
Stock-Based Comp., Other (Total)	30M	34M	27M	19M	1M
Total Stock-Based Compensation	30M	34M	27M	19M	1M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	2.12B	1.09B	1.95B	2.89B	2.71B
Short Term Investments	297M	242M	239M	580M	431M
Total Cash And Short Term Investments	2.41B	1.33B	2.19B	3.47B	3.14B
Accounts Receivable, Total	3.46B	3.54B	3.47B	3.53B	3.39B
Other Receivables	1B	946M	667M	614M	581M
Total Receivables	4.46B	4.48B	4.14B	4.14B	3.97B
Inventory	2.63B	3.18B	2.44B	2.57B	2.38B
Other Current Assets, Total	908M	1.43B	510M	850M	588M
Total Current Assets	10.41B	10.42B	9.28B	11.03B	10.07B
Gross Property Plant And Equipment	9.32B	9.63B	9.77B	9.99B	9.88B
Accumulated Depreciation	-5.41B	-5.72B	-6.04B	-6.19B	-6.1B
Net Property Plant And Equipment	3.91B	3.91B	3.73B	3.8B	3.78B
Long-term Investments	115M	138M	174M	180M	171M
Goodwill	13.15B	13.64B	13.57B	14.99B	13.85B
Other Intangibles, Total	3.49B	3.48B	3.42B	3.79B	3.4B
Deferred Tax Assets Long-Term	1.19B	1.18B	1.18B	1.12B	936M
Deferred Charges Long-Term	10M	15M	13M	11M	8M
Other Long-Term Assets, Total	388M	389M	360M	347M	320M
Total Assets	32.67B	33.18B	31.73B	35.27B	32.53B
Liabilities
Accounts Payable, Total	4.38B	4.62B	4.08B	4.24B	3.84B
Accrued Expenses, Total	757M	699M	777M	821M	733M
Short-term Borrowings	277M	516M	275M	387M	331M
Current Portion of Long-Term Debt	1.02B	545M	134M	1.14B	1.33B
Current Portion of Leases	121M	131M	119M	120M	108M
Current Income Taxes Payable	697M	548M	428M	467M	343M
Other Current Liabilities	2.01B	2.09B	1.95B	1.91B	1.73B
Total Current Liabilities	9.27B	9.15B	7.76B	9.09B	8.42B
Long-Term Debt	1.54B	1.85B	1.86B	2.05B	1.38B
Long-Term Leases	483M	549M	504M	593M	558M
Pension & Other Post Retirement Benefits	510M	417M	535M	569M	492M
Deferred Tax Liability Non Current	717M	735M	678M	741M	715M
Other Non Current Liabilities	354M	322M	391M	404M	388M
Total Liabilities	12.88B	13.02B	11.73B	13.44B	11.95B
Common Stock, Total	438M	438M	438M	438M	438M
Retained Earnings	20.36B	20.9B	21.36B	22.62B	23.82B
Treasury Stock	-91M	-870M	-1.05B	-1.05B	-1.91B
Comprehensive Income and Other	-992M	-388M	-825M	-273M	-1.86B
Total Common Equity	19.72B	20.08B	19.92B	21.73B	20.49B
Minority Interest	79M	74M	77M	90M	86M
Total Equity	19.79B	20.16B	20B	21.82B	20.58B
Total Liabilities And Equity	32.67B	33.18B	31.73B	35.27B	32.53B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	434M	422M	419M	419M	407M
ECS Total Common Shares Outstanding	434M	422M	419M	419M	407M
Book Value / Share	45.4	47.58	47.51	51.82	50.38
Tangible Book Value	3.07B	2.97B	2.93B	2.95B	3.24B
Tangible Book Value Per Share	7.07	7.03	6.99	7.04	7.97
Total Debt	3.44B	3.59B	2.9B	4.29B	3.71B
Net Debt	1.03B	2.26B	706M	820M	569M
Debt Equivalent of Unfunded Proj. Benefit Obligation	139M	99M	253M	273M	202M
Debt Equivalent Oper. Leases	184M	160M	120M	112M	112M
Minority Interest, Total (Incl. Fin. Div)	79M	74M	77M	90M	86M
Equity Method Investments, Total	4M	7M	7M	6M	7M
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	740M	911M	678M	718M	624M
Inventories - Work In Process, Total	142M	169M	137M	146M	155M
Inventories - Finished Goods, Total	1.73B	2.08B	1.61B	1.69B	1.59B
Inventories - Others	13M	15M	15M	16M	11M
Land - (BS)	3.3B	3.43B	2.6B	2.68B	2.72B
Buildings, Total	1.31B	1.34B	1.25B	1.27B	1.25B
Machinery, Total	4.32B	4.48B	4.49B	4.48B	4.42B
Full Time Employees	52.45K	51.2K	47.75K	47.15K	42.2K
Accumulated Allowance for Doubtful Accounts (Supple)	104M	102M	111M	103M	101M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	1.63B	1.26B	1.32B	2.01B	2.04B
Depreciation & Amortization - CF	561M	599M	585M	586M	557M
Amortization of Goodwill and Intangible Assets - (CF)	89M	83M	67M	69M	50M
Depreciation & Amortization, Total	650M	682M	652M	655M	607M
Amortization of Deferred Charges, Total - (CF)	62M	62M	50M	55M	53M
(Gain) Loss From Sale Of Asset	-46M	-46M	205M	6M	-46M
Asset Writedown & Restructuring Costs	266M	131M	216M	116M	18M
Other Operating Activities, Total	-70M	-160M	188M	248M	130M
Change In Accounts Receivable	-351M	-185M	47M	-50M	-31M
Change In Inventories	-391M	-722M	605M	-122M	93M
Change In Accounts Payable	328M	306M	-468M	187M	-255M
Change in Other Net Operating Assets	59M	-80M	442M	18M	-69M
Cash from Operations	2.14B	1.25B	3.26B	3.12B	2.54B
Capital Expenditure	-647M	-593M	-608M	-626M	-693M
Sale of Property, Plant, and Equipment	23M	27M	17M	16M	18M
Cash Acquisitions	-164M	-85M	-513M	-1.33B	-57M
Divestitures	257M	103M	368M	92M	194M
Investment in Marketable and Equity Securities, Total	51M	331M	-6M	-565M	137M
Net (Increase) Decrease in Loans Originated / Sold - Investing	1M	-	-	-	-
Other Investing Activities, Total	-	-	58M	86M	91M
Cash from Investing	-479M	-217M	-684M	-2.33B	-310M
Long-Term Debt Issued, Total	720M	819M	-	1.22B	-
Total Debt Issued	720M	819M	-	1.22B	-
Long-Term Debt Repaid, Total	-1.3B	-1.07B	-732M	-146M	-512M
Total Debt Repaid	-1.3B	-1.07B	-732M	-146M	-512M
Repurchase of Common Stock	-	-803M	-195M	-	-856M
Common Dividends Paid	-798M	-795M	-771M	-771M	-850M
Common & Preferred Stock Dividends Paid	-798M	-795M	-771M	-771M	-850M
Other Financing Activities, Total	82M	-37M	-56M	-135M	-73M
Cash from Financing	-1.29B	-1.89B	-1.75B	171M	-2.29B
Foreign Exchange Rate Adjustments	21M	-35M	-89M	-23M	-115M
Miscellaneous Cash Flow Adjustments	-	-135M	135M	-	-
Net Change in Cash	389M	-1.03B	863M	938M	-181M
Supplemental Items
Cash Interest Paid	60M	91M	101M	103M	109M
Cash Income Tax Paid (Refund)	651M	711M	505M	574M	651M
Levered Free Cash Flow	1.84B	498M	3B	1.67B	1.47B
Unlevered Free Cash Flow	1.87B	544M	3.07B	1.74B	1.54B
Change In Net Working Capital	-166M	989M	-1.27B	253M	158M
Net Debt Issued / Repaid	-578M	-253M	-732M	1.08B	-512M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	5.11	4.09	5.16	5.63	5.09
Return on Total Capital	7.19	5.74	7.18	7.7	6.85
Return On Equity %	8.65	6.28	6.67	9.72	9.71
Return on Common Equity	8.72	6.33	6.59	9.64	9.64
Margin Analysis
Gross Profit Margin %	45.19	42.3	45.75	50.6	50.85
SG&A Margin	30.06	30.44	31.57	33.63	34.11
EBITDA Margin %	15.4	12.03	14.8	16.33	15.79
EBITA Margin %	13.27	10	12.77	14.3	13.72
EBIT Margin %	12.83	9.63	12.46	13.98	13.47
Income From Continuing Operations Margin %	8.12	5.6	6.23	9.41	10.04
Net Income Margin %	8.14	5.62	6.13	9.3	9.93
Net Avail. For Common Margin %	8.14	5.62	6.13	9.3	9.93
Normalized Net Income Margin	7.85	5.72	7.35	8.34	8.07
Levered Free Cash Flow Margin	9.17	2.23	13.96	7.72	7.19
Unlevered Free Cash Flow Margin	9.32	2.43	14.27	8.04	7.49
Asset Turnover
Asset Turnover	0.64	0.68	0.66	0.64	0.6
Fixed Assets Turnover	5.28	5.73	5.63	5.73	5.41
Receivables Turnover (Average Receivables)	6.12	6.41	6.14	6.17	5.93
Inventory Turnover (Average Inventory)	4.57	4.45	4.15	4.25	4.07
Short Term Liquidity
Current Ratio	1.12	1.14	1.2	1.21	1.2
Quick Ratio	0.74	0.63	0.82	0.84	0.84
Operating Cash Flow to Current Liabilities	0.23	0.14	0.42	0.34	0.3
Days Sales Outstanding (Average Receivables)	59.68	56.97	59.43	59.34	61.58
Days Outstanding Inventory (Average Inventory)	79.93	82.03	87.94	86.03	89.62
Average Days Payable Outstanding	133.01	121.97	145.12	141.08	149.3
Cash Conversion Cycle (Average Days)	6.59	17.02	2.25	4.29	1.9
Long Term Solvency
Total Debt/Equity	17.39	17.8	14.48	19.65	18.02
Total Debt / Total Capital	14.81	15.11	12.65	16.43	15.27
LT Debt/Equity	10.24	11.88	11.84	12.11	9.43
Long-Term Debt / Total Capital	8.72	10.09	10.34	10.12	7.99
Total Liabilities / Total Assets	39.41	39.25	36.97	38.12	36.74
EBIT / Interest Expense	55.96	29.55	25.29	26.71	27.89
EBITDA / Interest Expense	70.09	38.89	31.44	32.5	34.02
(EBITDA - Capex) / Interest Expense	56.02	30.77	25.71	26.96	27.02
Total Debt / EBITDA	1.07	1.26	0.87	1.17	1.1
Net Debt / EBITDA	0.32	0.79	0.21	0.22	0.17
Total Debt / (EBITDA - Capex)	1.34	1.6	1.06	1.41	1.39
Net Debt / (EBITDA - Capex)	0.4	1	0.26	0.27	0.21
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	4.24	11.62	-3.94	0.33	-5.05
Gross Profit, 1 Yr. Growth %	0.85	4.48	3.9	10.97	-3.7
EBITDA, 1 Yr. Growth %	11.63	-16.65	18.54	18.57	-2.74
EBITA, 1 Yr. Growth %	13.75	-16.14	22.68	21.54	-2.87
EBIT, 1 Yr. Growth %	14.86	-16.46	24.29	22.04	-2.27
Earnings From Cont. Operations, 1 Yr. Growth %	14.4	-23.02	6.86	51.64	1.28
Net Income, 1 Yr. Growth %	16.05	-22.95	4.69	52.28	1.4
Normalized Net Income, 1 Yr. Growth %	18.5	-18.98	23.47	24.08	-1.59
Diluted EPS Before Extra, 1 Yr. Growth %	16.05	-21.9	6.86	52.41	2.61
Accounts Receivable, 1 Yr. Growth %	11.27	2.29	-1.81	1.73	-4.08
Inventory, 1 Yr. Growth %	20.16	20.96	-23.14	5.03	-7.58
Net Property, Plant and Equip., 1 Yr. Growth %	5.99	0.05	-4.58	1.77	-0.45
Total Assets, 1 Yr. Growth %	8.04	1.54	-4.35	11.16	-7.7
Tangible Book Value, 1 Yr. Growth %	72.49	-3.32	-1.48	0.41	9.49
Common Equity, 1 Yr. Growth %	10.91	1.87	-0.8	9.09	-5.7
Cash From Operations, 1 Yr. Growth %	-30.49	-41.76	161.03	-4.15	-18.75
Capital Expenditures, 1 Yr. Growth %	-9.51	-8.35	2.53	2.96	10.7
Levered Free Cash Flow, 1 Yr. Growth %	-3.76	-72.98	503.69	-41.95	-4.43
Unlevered Free Cash Flow, 1 Yr. Growth %	-4.44	-70.96	465.18	-40.86	-4.77
Dividend Per Share, 1 Yr. Growth %	0	0	0	10.27	1.47
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-0.12	7.86	3.55	-1.83	-2.4
Gross Profit, 2 Yr. CAGR %	-1.28	2.65	4.19	7.38	2.9
EBITDA, 2 Yr. CAGR %	-8.58	-1.35	-0.75	14.54	4.35
EBITA, 2 Yr. CAGR %	-9.8	-2.18	1.43	17.39	5.2
EBIT, 2 Yr. CAGR %	-9.8	-1.89	1.9	18.29	5.66
Earnings From Cont. Operations, 2 Yr. CAGR %	-11.99	-6.16	-9.3	27.3	23.93
Net Income, 2 Yr. CAGR %	-11.47	-5.44	-10.19	26.26	24.26
Normalized Net Income, 2 Yr. CAGR %	-9.1	-1.86	0.02	18.58	6.74
Diluted EPS Before Extra, 2 Yr. CAGR %	-11.47	-4.79	-8.64	27.62	25.05
Accounts Receivable, 2 Yr. CAGR %	0.6	6.68	0.22	-0.07	-1.22
Inventory, 2 Yr. CAGR %	9.64	20.56	-3.58	-10.14	-1.42
Net Property, Plant and Equip., 2 Yr. CAGR %	1.76	2.98	-2.29	-1.4	0.55
Total Assets, 2 Yr. CAGR %	1.99	4.75	-1.46	3.11	1.26
Tangible Book Value, 2 Yr. CAGR %	55.34	29.05	-2.26	-0.4	5.04
Common Equity, 2 Yr. CAGR %	3.17	6.29	0.52	4.02	1.43
Cash From Operations, 2 Yr. CAGR %	-18.72	-36.37	23.3	58.18	-11.75
Capital Expenditures, 2 Yr. CAGR %	-2.24	-8.93	-3.06	2.74	6.76
Levered Free Cash Flow, 2 Yr. CAGR %	-5.8	-48.95	27.59	82.98	-28.33
Unlevered Free Cash Flow, 2 Yr. CAGR %	-6.3	-47.27	27.99	78.8	-27.67
Dividend Per Share, 2 Yr. CAGR %	0	0	0	5.01	5.78
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	0.28	3.65	3.78	2.46	-2.91
Gross Profit, 3 Yr. CAGR %	-0.65	0.61	3.06	6.4	3.23
EBITDA, 3 Yr. CAGR %	-7	-10.01	4.78	2.93	6.41
EBITA, 3 Yr. CAGR %	-8.14	-11.87	5.49	4.94	7.86
EBIT, 3 Yr. CAGR %	-8.22	-11.99	6.16	5.34	8.58
Earnings From Cont. Operations, 3 Yr. CAGR %	-11.25	-15.83	-2.01	7.65	17.95
Net Income, 3 Yr. CAGR %	-10.95	-15.48	-2.18	7.09	17.36
Normalized Net Income, 3 Yr. CAGR %	-8.06	-12.43	5.94	4.44	8.89
Diluted EPS Before Extra, 3 Yr. CAGR %	-10.95	-15.09	-1.06	8.35	18.67
Accounts Receivable, 3 Yr. CAGR %	-1.44	1.16	3.77	0.71	-1.43
Inventory, 3 Yr. CAGR %	6.49	13.29	3.76	-0.78	-9.26
Net Property, Plant and Equip., 3 Yr. CAGR %	7.75	1.19	0.4	-0.92	-1.16
Total Assets, 3 Yr. CAGR %	3.39	1.84	1.62	2.58	-0.64
Tangible Book Value, 3 Yr. CAGR %	100.88	32.57	18.06	-1.29	2.92
Common Equity, 3 Yr. CAGR %	5.24	2.73	3.87	3.3	0.68
Cash From Operations, 3 Yr. CAGR %	-7.42	-27.27	1.86	13.37	26.68
Capital Expenditures, 3 Yr. CAGR %	-8.22	-4.32	-5.26	-1.09	5.33
Levered Free Cash Flow, 3 Yr. CAGR %	4.83	-37.83	16.23	-3.35	43.62
Unlevered Free Cash Flow, 3 Yr. CAGR %	4.41	-36.54	16.2	-2.51	41.4
Dividend Per Share, 3 Yr. CAGR %	0	0	0	3.31	3.82
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.4	2.26	1.57	1.42	1.26
Gross Profit, 5 Yr. CAGR %	-0.04	0	1.26	3.26	3
EBITDA, 5 Yr. CAGR %	-2.78	-7.07	-3.68	-0.95	3.17
EBITA, 5 Yr. CAGR %	-3.57	-8.47	-4.37	-1.16	3.73
EBIT, 5 Yr. CAGR %	-3.58	-8.19	-4.24	-0.94	4.26
Earnings From Cont. Operations, 5 Yr. CAGR %	-4.89	-13.17	-10.47	-0.68	7.64
Net Income, 5 Yr. CAGR %	-4.46	-12.95	-10.65	-0.76	7.64
Normalized Net Income, 5 Yr. CAGR %	-3.44	-8.64	-4.85	-1.14	4.45
Diluted EPS Before Extra, 5 Yr. CAGR %	-4.46	-12.72	-10.04	-0.06	8.66
Accounts Receivable, 5 Yr. CAGR %	0.63	-0.05	-0.78	0.66	1.74
Inventory, 5 Yr. CAGR %	6.29	8.87	2.34	3.26	1.66
Net Property, Plant and Equip., 5 Yr. CAGR %	6.25	5.4	3.61	0.14	0.48
Total Assets, 5 Yr. CAGR %	3.17	3.2	1.42	2.34	1.47
Tangible Book Value, 5 Yr. CAGR %	42.82	93.98	50.55	18.31	12.73
Common Equity, 5 Yr. CAGR %	5.55	5.22	3.33	3.25	2.89
Cash From Operations, 5 Yr. CAGR %	-5.56	-12.76	3.82	-0.76	-3.82
Capital Expenditures, 5 Yr. CAGR %	3.04	-3.26	-6.19	-1.55	-0.62
Levered Free Cash Flow, 5 Yr. CAGR %	-0.5	-18.88	13.45	-4.3	-5.08
Unlevered Free Cash Flow, 5 Yr. CAGR %	-0.36	-17.84	13.32	-4	-4.73
Dividend Per Share, 5 Yr. CAGR %	2.69	0.66	0	1.97	2.27